dailymed zepbound tirzepatide label These highlights do not include all the information needed to use safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND® (tirzepatide) Injection, for subcutaneous useInitial U.S. Approval: 2022 https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and

Description

Concurrent medications

Se ha propuesto que posibles diferencias en la respuesta a los receptores GLP-1 o en la farmacocintica del medicamento podran contribuir a una respuesta reducida, aunque estas hiptesis requieren ms investigacin

LBA 11, LBA 21, LBA 33, LBA 74 Rothenbhler, M

These include nausea, diarrhea, and vomiting

Drug Interaction Mechanisms and What You Should Know Semaglutide and metoprolol do not have direct pharmacokinetic interactions (metabolism or clearance)